Literature DB >> 30198602

Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology.

Jennifer H MacLachlan1,2, Benjamin C Cowie1,2,3.   

Abstract

OBJECTIVE: To estimate the cultural and linguistic diversity in Australians currently living with chronic hepatitis B (CHB), the majority of whom were born overseas, and to identify trends in this diversity over time.
METHODS: Estimates were generated by combining Australian census country of birth information with seroprevalence data generated from antenatal serology linked with surveillance notifications. The number of people living with CHB was assessed according to country of birth using the 2011 and 2016 censuses.
RESULTS: The total number of Australian residents living with CHB increased by 20% between 2011 and 2016, substantially outpacing population growth. The most common country of birth continued to be China, with the number of Chinese-born Australians living with CHB increasing by 60% in the 5-year period. Decreased numbers were observed for people born in European countries.
CONCLUSIONS: The epidemiology of chronic hepatitis B in Australia has shifted over time due to changing migration patterns, with increases in many countries in the Asia-Pacific, African and Middle Eastern regions. Implications for public health: Interventions to improve the health of people living with CHB are imperative, and these up-to-date estimates identify priority groups and communities, which are constantly changing.
© 2018 The Authors.

Entities:  

Keywords:  epidemiology; hepatitis B; migrant health; modelling

Mesh:

Year:  2018        PMID: 30198602     DOI: 10.1111/1753-6405.12826

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

1.  Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries.

Authors:  Elizabeth Ortiz; Brighid Scanlon; Amy Mullens; Jo Durham
Journal:  J Community Health       Date:  2020-02

2.  Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression.

Authors:  Caorui Lin; Ying Huang; Linjie Luo; Fengling Fang; Jiawei Zhang; Zhen Xun; Ya Fu; Hongyan Shang; Can Liu; Qishui Ou
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

3.  Modeling Progress Toward Elimination of Hepatitis B in Australia.

Authors:  Karen McCulloch; Nicole Romero; Jennifer MacLachlan; Nicole Allard; Benjamin Cowie
Journal:  Hepatology       Date:  2019-10-14       Impact factor: 17.425

Review 4.  Definitions of Culturally and Linguistically Diverse (CALD): A Literature Review of Epidemiological Research in Australia.

Authors:  Thi Thu Le Pham; Janneke Berecki-Gisolf; Angela Clapperton; Kerry S O'Brien; Sara Liu; Katharine Gibson
Journal:  Int J Environ Res Public Health       Date:  2021-01-16       Impact factor: 3.390

5.  Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia.

Authors:  Jack Wallace; Yinzong Xiao; Jess Howell; Alex Thompson; Nicole Allard; Emily Adamson; Jacqui Richmond; Behzad Hajarizadeh; Melanie Eagle; Joseph Doyle; Margaret Hellard
Journal:  BMC Public Health       Date:  2022-03-18       Impact factor: 3.295

6.  Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.

Authors:  Syed Hassan Bin Usman Shah; Maryam Alavi; Behzad Hajarizadeh; Gail V Matthews; Marianne Martinello; Mark Danta; Janaki Amin; Matthew G Law; Jacob George; Heather Valerio; Gregory J Dore
Journal:  JHEP Rep       Date:  2022-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.